PAVmed (PAVM) Gross Margin (2021 - 2025)
PAVmed's (PAVM) quarterly Gross Margin came in at 4.94% in Q4 2025, up 37506.0% year-on-year from N/an in Q4 2024, and up 99.51% quarter-over-quarter from 1000.0% in Q3 2025.
PAVmed (PAVM) Gross Margin (2021 - 2025) Analysis & Trends
PAVmed's Gross Margin history runs 5 years deep, the most recent figure standing at 4.94% for Q4 2025.
- On a quarterly basis, Gross Margin rose 37506.0% year-over-year to 4.94% in Q4 2025; TTM through Dec 2025 was 117.0%, a 5069.0% decrease from a year earlier, with the FY2025 full-year figure at 118.0%, down 5640.0% from the prior year.
- Gross Margin advanced to 4.94% in Q4 2025 per PAVM's latest filing, from 1000.0% in the prior quarter.
- Across five years, Gross Margin topped out at 28.0% in Q3 2021 and bottomed at 2039.47% in Q3 2022.
- The 5-year median for Gross Margin is 163.35% (2023), against an average of 453.43%.
- Across the five-year window, Gross Margin slumped 206747 bps in 2022 and soared 191457 bps in 2023, its largest moves.
- Year by year, Gross Margin stood at 47.0% in 2021, then sank by 2761 bps to 1344.64% in 2022, then soared by 96 bps to 53.57% in 2023, then tumbled by 609 bps to 380.0% in 2024, then surged by 99 bps to 4.94% in 2025.
- Per Business Quant, the three latest PAVM Gross Margin figures stand at 4.94% (Q4 2025), 1000.0% (Q3 2025), and 583.33% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | -4.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.94% |
| Sep 30, 2025 | -1,000.00% |
| Jun 30, 2025 | -583.33% |
| Mar 31, 2025 | -350.00% |
| Dec 31, 2024 | -380.00% |
| Jun 30, 2024 | -70.17% |
| Mar 31, 2024 | -72.67% |
| Dec 31, 2023 | -53.57% |
| Sep 30, 2023 | -124.91% |
| Jun 30, 2023 | -915.06% |
| Mar 31, 2023 | -201.79% |
| Dec 31, 2022 | -1,344.64% |
| Sep 30, 2022 | -2,039.47% |
| Mar 31, 2022 | -95.24% |
| Dec 31, 2021 | -47.00% |
| Sep 30, 2021 | 28.00% |